Wenfeng Zeng

5.5k total citations · 3 hit papers
63 papers, 4.0k citations indexed

About

Wenfeng Zeng is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Wenfeng Zeng has authored 63 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Spectroscopy. Recurrent topics in Wenfeng Zeng's work include Advanced Proteomics Techniques and Applications (13 papers), Nanoplatforms for cancer theranostics (12 papers) and Mass Spectrometry Techniques and Applications (10 papers). Wenfeng Zeng is often cited by papers focused on Advanced Proteomics Techniques and Applications (13 papers), Nanoplatforms for cancer theranostics (12 papers) and Mass Spectrometry Techniques and Applications (10 papers). Wenfeng Zeng collaborates with scholars based in China, United States and Singapore. Wenfeng Zeng's co-authors include Xiaowei Zeng, Lin Mei, Hongzhong Chen, Zimu Li, Yanli Zhao, Wei Liang, Wei Cheng, Fayun Zhang, Lingtao Jin and Hao Chi and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and ACS Nano.

In The Last Decade

Wenfeng Zeng

63 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine

2019 880 citations Wenfeng Zeng et al. profile →
A high-speed search engine pLink 2 with systematic evaluation for proteome-scale identification of cross-linked peptides

2019 329 citations Chao Liu, Wenfeng Zeng et al. profile →
Artificial intelligence for proteomics and biomarker discovery

2021 216 citations Matthias Mann, Wenfeng Zeng et al. profile →

Peers

Countries citing papers authored by Wenfeng Zeng

Since Specialization

Citations

This map shows the geographic impact of Wenfeng Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Zeng more than expected).

Fields of papers citing papers by Wenfeng Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Zeng. The network helps show where Wenfeng Zeng may publish in the future.

Co-authorship network of co-authors of Wenfeng Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Zeng. A scholar is included among the top collaborators of Wenfeng Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Zeng. Wenfeng Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk analysis of noise-induced hearing loss of workers in the automobile manufacturing industries based on back-propagation neural network model: a cross-sectional study in Han Chinese population 2024 ·BMJ Open ·(unknown), Guanhao Huang, Jinwei Zhang, (unknown), Chunrong Gu, Xing Rong, Lili Huang, Wenfeng Zeng, (unknown)	2
2	EGR1 Promotes Erastin-induced Ferroptosis Through Activating Nrf2-HMOX1 Signaling Pathway in Breast Cancer Cells 2024 ·Journal of Cancer ·(unknown), Zifei Liu, (unknown), Yunyi Zhang, Xinyu Yang, (unknown), Ruihua Zhang, Wenfeng Zeng, Chang Gong, Jianing Chen	6
3	Stable IL‐2 Nano‐Assembly for Improved Anti‐Tumor Effect 2023 ·Advanced Therapeutics ·(unknown), Wenfeng Zeng, (unknown), Xiuli Wei, Kai Song, (unknown), Ping Zhu, Hao Wang, Wei Liang	1
4	Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage 2023 ·Molecular Biology Reports ·Yuwan Zhao, Xinghua Lin, Wenfeng Zeng, (unknown), (unknown), Sheng Gao, Jianjun Liu, Zhuo Li	8
5	PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer 2023 ·Breast Cancer Research ·Fayun Zhang, (unknown), Luoyang Wang, Wenfeng Zeng, Wenjing Wei, Chunling Zhang, Ziran Zhao, Wei Liang	9
6	The structural context of posttranslational modifications at a proteome-wide scale 2022 ·PLoS Biology ·Isabell Bludau, Sander Willems, Wenfeng Zeng, Maximilian T. Strauss, Fynn M. Hansen, Maria C. Tanzer, Özge Karayel, Brenda A. Schulman, Matthias Mann	64
7	Accurate Proteoform Identification and Quantitation Using pTop 2.0 2022 ·Methods in molecular biology ·Rui-Xiang Sun, Ruimin Wang, Lan Luo, Chao Liu, Hao Chi, Wenfeng Zeng, Si‐Min He	2
8	Downregulating testosterone levels enhance immunotherapy efficiency 2021 ·OncoImmunology ·Luoyang Wang, Guoqiang Jiang, Nan Jing, (unknown), (unknown), Wenfeng Zeng, Wei Liang, Zheng Liu	10
9	Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity 2021 ·Communications Biology ·Fayun Zhang, (unknown), Apurba Kumar Barman, Zihao Wang, Luyao Wang, Wenfeng Zeng, Luoyang Wang, Qin Yan, (unknown), Chunling Zhang, Wei Liang	13
10	Role of CASP7 polymorphisms in noise-induced hearing loss risk in Han Chinese population 2021 ·Scientific Reports ·(unknown), Jinwei Zhang, (unknown), Wenfeng Zeng, Lili Huang, Chunrong Gu, Keping Liu, (unknown), Zhi Wang	2
11	PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction 2020 ·Cell Reports ·Xiaozhe Yin, Wenfeng Zeng, Bowen Wu, Luoyang Wang, Zihao Wang, Hongjian Tian, Luyao Wang, (unknown), Ryan Clay, Xiuli Wei, Qin Yan, Fayun Zhang, Chunling Zhang, Lingtao Jin, Wei Liang	131
12	Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Chao Zhang, Wenfeng Zeng, Yi Yao, Bin Xu, Xiuli Wei, Luoyang Wang, Xiaozhe Yin, Apurba Kumar Barman, Fayun Zhang, Chunling Zhang, Qibin Song, Wei Liang	40
13	Naringenin as a potential immunomodulator in therapeutics 2018 ·Pharmacological Research ·Wenfeng Zeng, Lingtao Jin, Fayun Zhang, Chunling Zhang, Wei Liang	209
14	Comparative study of reproductive organs and egg quality characteristics in hyline and domestic layer breeds. 2015 ·Pakistan Veterinary Journal ·(unknown), (unknown), Wenfeng Zeng, Yuling Mi, (unknown)	5
15	Chrysin promotes osteogenic differentiation via ERK/MAPK activation 2013 ·Protein & Cell ·Wenfeng Zeng, Yan Yan, Fayun Zhang, Chunling Zhang, Wei Liang	68
16	The effect of graphene oxide on conformation change, aggregation and cytotoxicity of HIV-1 regulatory protein (Vpr) 2012 ·Biomaterials ·Min Zhang, Xiaobo Mao, Chenxuan Wang, Wenfeng Zeng, Chunling Zhang, Zhongjun Li, Ying Fang, Yanlian Yang, Wei Liang, (unknown), (unknown)	49
17	Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells 2012 ·PLoS ONE ·Changjie Lou, Fayun Zhang, Ming Yang, Juan Zhao, Wenfeng Zeng, Xiaocui Fang, Yanqiao Zhang, Chunling Zhang, Wei Liang	88
18	Stability Influences the Biodistribution, Toxicity, and Anti-tumor Activity of Doxorubicin Encapsulated in PEG-PE Micelles in Mice 2012 ·Pharmaceutical Research ·Xiuli Wei, Yiguang Wang, Wenfeng Zeng, Feng Huang, Lei Qin, Chunling Zhang, Wei Liang	18
19	Pegylated Phosphotidylethanolamine Inhibiting P-Glycoprotein Expression and Enhancing Retention of Doxorubicin in MCF7/ADR Cells 2011 ·Journal of Pharmaceutical Sciences ·Jing Wang, Hui Qu, Lingtao Jin, Wenfeng Zeng, Lei Qin, Fayun Zhang, Xiuli Wei, Wan-Liang Lü, Chunling Zhang, Wei Liang	27
20	Bis(di-2-pyridylphosphinato-κ³N,O,N′)copper(II) dichloromethane disolvate 2003 ·Acta Crystallographica Section C Crystal Structure Communications ·Michael Y. Chiang, Jing‐Yun Wu, Wenfeng Zeng, Duan‐Jun Xu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact